secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOHNSON & JOHNSON (JNJ)
CIK:        0000200406
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0000200406-23-000115
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eugene A. Woods elected to Johnson & Johnson Board of Directors
---------------------------------------------------------------

- Eugene A. Woods, CEO of Advocate Health, joined the board as a non-employee director effective Nov 30, 2023.
- Mr. Woods will receive standard non-employee director compensation as described in 2023 Proxy Statement.
- Advocate Health purchased ~$175M of Johnson & Johnson products in FY2022; JNJ paid <$1M for clinical trials.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/200406/000020040623000115/0000200406-23-000115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/200406/000020040623000115/jnj-20231130.htm
  HTML page:      https://secwatch.observer/filing/0000200406-23-000115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer